$P

Giancarlo Charles H sold $6.9M of P

Giancarlo Charles H (CEO) sold 70,000 shares of Everpure, Inc. (P) at an average of $98.94 ($94.63–$101.99, $6.93M total) across 8 trades on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Giancarlo Charles H
Published Aug 12, 2026, 9:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$P
Neutral
medium confidence
Mentioned
$P
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity but does not include new company fundamentals such as earnings, guidance, deals, or regulatory actions.

02

Market read

Traders may treat this as a mild sentiment input, but it is unlikely to drive a durable repricing without additional company-specific catalysts.

03

What to watch

The article does not state sale motivation, tax considerations, or whether other insiders sold/bought around the same time, which limits inference from this single Form 4.

Relevance 5/10Novelty 2/10Timing: filed 2026-08-12 for trades dated 2026-08-10

Background

The filing is an SEC Form 4 insider transaction by Everpure CEO Giancarlo Charles H, executed via a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$PNeutralMedium confidence
Context

Everpure CEO Giancarlo Charles H sold about 70,000 shares in open-market trades under a 10b5-1 plan, worth about $6.93M.

Expected impact

Likely limited near-term impact; any effect would be short-lived unless paired with other company-specific news.

Evidence & confidence

Form 4 shows a pre-arranged 10b5-1 plan and an open-market sale, which typically reduces the likelihood of immediate negative information content.

Market effects

No clear sector read-through from a single CEO 10b5-1 sale without accompanying guidance, contract, or regulatory news.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private concerns, so traders may watch for follow-on disclosures (earnings, guidance changes, financing) rather than dismissing it as purely routine.

Key entities

  • Everpure, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Giancarlo Charles H

    CEO and reporting person who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.

$PMed

Needham raises Everpure stock price target on strong FY28 outlook

Needham raised its price target for Everpure (NYSE:P) to $150 from $140, maintaining a Buy rating. The firm cited Everpure's strong fiscal 2028 outlook, with projected revenue growth of 39% to 45% and operating margins of 24% to 26%. The company also reported second-quarter fiscal 2027 revenue of $1.186 billion, up 38% year-over-year. Several analysts have revised earnings upwards, and the stock has returned 68.3% over the last six months.